METICORTEN Drug Patent Profile
✉ Email this page to a colleague
When do Meticorten patents expire, and when can generic versions of Meticorten launch?
Meticorten is a drug marketed by Schering and is included in one NDA.
The generic ingredient in METICORTEN is prednisone. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meticorten
A generic version of METICORTEN was approved as prednisone by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METICORTEN?
- What are the global sales for METICORTEN?
- What is Average Wholesale Price for METICORTEN?
Summary for METICORTEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 114 |
Patent Applications: | 4,423 |
DailyMed Link: | METICORTEN at DailyMed |
Recent Clinical Trials for METICORTEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 2 |
ADC Therapeutics | Phase 2 |
Joseph Tuscano | Phase 2 |
US Patents and Regulatory Information for METICORTEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | METICORTEN | prednisone | TABLET;ORAL | 009766-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | METICORTEN | prednisone | TABLET;ORAL | 009766-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |